These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2525433)

  • 21. Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice.
    Zarrindast MR; Habibi-Moini S
    Gen Pharmacol; 1991; 22(6):1023-6. PubMed ID: 1687392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of SCH 23390 and sulpiride on the reinforced responding of the young rat.
    McDougall SA; Nonneman AJ; Crawford CA
    Behav Neurosci; 1991 Oct; 105(5):744-54. PubMed ID: 1840013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
    Kostrzewa RM; Kastin AJ
    Brain Res Bull; 1993; 31(6):707-12. PubMed ID: 8100182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.
    Banasikowski TJ; Beninger RJ
    Int J Neuropsychopharmacol; 2012 Nov; 15(10):1525-34. PubMed ID: 22093169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
    Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
    Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lesions of the entopeduncular nucleus and the subthalamic nucleus reduce dopamine receptor antagonist-induced catalepsy in the rat.
    Zadow B; Schmidt WJ
    Behav Brain Res; 1994 May; 62(1):71-9. PubMed ID: 7917035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D1 antagonists potentiate the durations of bar and cling catalepsy and the dorsal immobility response in rats.
    Meyer ME; Cottrell GA; Van Hartesveldt C
    Pharmacol Biochem Behav; 1992 Mar; 41(3):507-10. PubMed ID: 1533938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
    Papa SM; Engber TM; Boldry RC; Chase TN
    Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
    Iorio LC; Cohen M; Coffin VL
    J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat.
    Koob GF; Le HT; Creese I
    Neurosci Lett; 1987 Aug; 79(3):315-20. PubMed ID: 2958724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological and behavioral effects of D1 dopamine antagonists.
    Barnett A; Iorio LC; McQuade R; Chipkin RE
    Adv Exp Med Biol; 1988; 235():137-44. PubMed ID: 2976247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats.
    Bordi F; Meller E
    Brain Res; 1989 Dec; 504(2):276-83. PubMed ID: 2574622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further studies of the mechanism behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in rats.
    Arnt J; Hyttel J; Bach-Lauritsen T
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):319-24. PubMed ID: 2879412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental plasticity in the D1- and D2-mediation of motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Ughrin Y; Bruno JP
    Dev Psychobiol; 1996 Dec; 29(8):653-66. PubMed ID: 8958479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactive effects of D1 and D2 agonists with scopolamine on radial-arm maze performance.
    Levin ED; Rose JE
    Pharmacol Biochem Behav; 1991 Feb; 38(2):243-6. PubMed ID: 1676165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists.
    Anderson JJ; Kask AM; Chase TN
    Eur J Pharmacol; 1996 Jan; 295(2-3):163-8. PubMed ID: 8720580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.